senate · trading 2016-10-11 → 2023-08-08
*Purchases reported over roughly the last three years, weighted by the midpoint of each disclosed dollar band and marked to the latest close. Filings state a range, never a share count, so this tracks the stock rather than the position. It is not a dollar figure and it is not what this member made.
▮ buys · ▮ sells
| Date | Ticker | Type | Amount | Est. price | Latest close | Return |
|---|---|---|---|---|---|---|
| 2023-08-08 | ROAD | SELL | $250K–$500K | $33.94 | $104.68 2026-09-04 | -208.4% exit |
| 2022-01-31 | ROAD | SELL | $100K–$250K | $26.24 | $104.68 2026-09-04 | -298.9% exit |
| 2021-10-14 | ROAD | SELL | $50K–$100K | $34.75 | $104.68 2026-09-04 | -201.2% exit |
| 2019-02-20 | ZAYO | SELL | $250K–$500K | $25.74 | $34.99 2020-03-06 | -35.9% exit |
| 2019-02-19 | ZAYO | SELL | $500K–$1.0M | $25.45 | $34.99 2020-03-06 | -37.5% exit |
| 2019-02-19 | CHTR | SELL | $1.0M–$5.0M | $348.43 | $151.99 2026-09-04 | +56.4% exit |
| 2017-11-06 | HALO | SELL | $500K–$1.0M | $17.01 | $110.19 2026-09-04 | -547.8% exit |
| 2017-10-18 | ZIOP | SELL | $250K–$500K | $5.75 | $0.87 2022-01-26 | +84.9% exit |
| 2017-10-18 | XON | SELL | $1.0M–$5.0M | $18.24 | $4.08 2020-02-11 | +77.6% exit |
| 2016-10-11 | GSK | BUY | $1K–$15K | $42.14 | $51.10 2026-10-26 | +21.3% |
Buys are marked to the latest close and treated as still open. A sell tagged rt closes an earlier disclosed buy in the same name. exit reads from the seller's side: how the stock moved after they were out.
| Member | Shared tickers |
|---|---|
| Rohit Khanna | 2 · GSK, CHTR |
| Alan S. Lowenthal | 2 · CHTR, ZAYO |
| K. Michael Conaway | 2 · GSK, CHTR |
| Kurt Schrader | 2 · GSK, CHTR |
| George Holding | 2 · GSK, CHTR |
| James B. Renacci | 1 · GSK |
| Josh Gottheimer | 1 · HALO |
| Thomas H Tuberville | 1 · GSK |
| Thomas R Carper | 1 · GSK |
| Virginia Foxx | 1 · GSK |
| John Boozman | 1 · GSK |
| Gilbert Cisneros | 1 · HALO |